Tizanidine Hcl Capsule
Product Images NDC 80425-0090

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine Hcl (NDC 80425-0090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

FDA Label Image

Fig 2

FDA Label Image

Fig 3

Fig 3
This text describes a study that evaluated the effect of tizanidine at a mean dose of 26.8 mg on the Ashworth score. The Ashworth score is a measure of spasticity in individuals with conditions such as spinal cord injury, multiple sclerosis, or cerebral palsy. The text provides data for the end of titration, end of maintenance, and endpoint, as well as the study week for each.*
FDA Label Image

Structure

FDA Label Image

Tizanidine HCl 4mg Cap Qty 60 Ndc 80425 0090

Tizanidine HCl 4mg Cap Qty 60 Ndc 80425 0090
This is a label of a medication called Tizanidine HCL 4mg Capsule. It also displays its package identification number as 460. The medicine was packed by a company called AAdvance and the code T473021 might be a reference code for their internal tracking purposes.*
FDA Label Image

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0090

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0090
This is a pack of 50 capsules of Tizanidine HCL 4mg. The packaging was done by AAdvanced company.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.